Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company’s leading position is already being tested by Novo Nordisk’s GLP-1 weight loss pill.
Source: https://www.fool.com/investing/2026/01/23/forget-eli-lilly-b…
Multiple headwinds in the homebuilding market have caused the stocks of D.R. Horton and Lennar to fall.
The AI revolution will require a lot of power in the coming years. Google has signed energy deals with NextEra and Brookfield Renewable.
Nvidia continues to blow expectations away. Microsoft stock has rarely been this cheap on an earnings basis in recent years.
